Ukr.Biochem.J. 2015; Volume 87, Issue 3, May-Jun, pp. 98-106


Levels of serum antibodies to enterobacterial lipopolysaccharides and their relationship with concentration of C-reactive protein in diabetes mellitus patients

A. I. Gordienko

S. I. Georgievsky Crimea state medical university, Simferopol;

We examined patients with type 1 (DM 1) and type 2 (DM 2) diabetes mellitus. The concentration of C-reactive protein (CRP) in the blood and levels of serum antibodies to different classes of enterobacterial lipopolysaccharides (LPS) were determined by ELISA. Using cluster analysis it was shown that in 40.8% DM-1 patients the increased concentration of CRP is associated with a decrease in the levels of serum anti-LPS-IgA, anti-LPS-IgM and anti-LPS-IgG. In 56.7% of DM-2 patients with increased concentration of CRP levels of serum anti-LPS-IgA and anti-LPS-IgM were not significantly different from the normal values, but the levels of serum anti-LPS-IgG were significantly increased. Activation of inflammation and increase of concentration of the CRP in the blood of DM-2 patients is accompanied by a significant increase in the levels of serum anti-LPS-A and anti-LPS-G, as well as the tendency to reduce the levels of anti-LPS-IgM. The results of this study suggest an association between low intensity inflammation and immune response to enterobacterial LPS  in type 1 and 2 diabetes mellitus.

Keywords: , , , ,


  1. Mangiapane H. Cardiovascular disease and diabetes. Adv Exp Med Biol. 2012;771:219-28. Review. PubMed, CrossRef
  2. Rosenfeld ME. Inflammation and atherosclerosis: direct versus indirect mechanisms. Curr Opin Pharmacol. 2013 Apr;13(2):154-60. Review.  PubMed, PubMedCentral, CrossRef
  3. Pfützner A, Forst T. High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus. Diabetes Technol Ther. 2006 Feb;8(1):28-36. Review. PubMed, CrossRef
  4. Titov VN. Diagnostic value of increasing the level of C-reactive protein in clinical and subclinical intervals. Klin Lab Diagnostica. 2004;(6):3-10. (In Russian).
  5. Konev IuV, Lazebnik LB. Endotoxin (LPS) in the pathogenesis of atherosclerosis. Eksp Klin Gastroenterol. 2011;(11):15-26. Russian. PubMed
  6. Stoll LL, Denning GM, Weintraub NL. Potential role of endotoxin as a proinflammatory mediator of atherosclerosis. Arterioscler Thromb Vasc Biol. 2004 Dec;24(12):2227-36. Review. PubMed, CrossRef
  7. Heine H, Rietschel ET, Ulmer AJ. The biology of endotoxin. Mol Biotechnol. 2001 Nov;19(3):279-96. Review. PubMed, CrossRef
  8. Liebers V, Raulf-Heimsoth M, Brüning T. Health effects due to endotoxin inhalation (review). Arch Toxicol. 2008 Apr;82(4):203-10. Review. PubMed, CrossRef
  9. Cross AS. Anti-endotoxin vaccines: back to the future. Virulence. 2014 Jan 1;5(1):219-25. Review. PubMed, PubMedCentral, CrossRef
  10. Müller-Loennies S, Brade L, Brade H. Neutralizing and cross-reactive antibodies against enterobacterial lipopolysaccharide. Int J Med Microbiol. 2007 Sep;297(5):321-40. Review. PubMed, CrossRef
  11. Demicheva TP. Gastroenterological aspects of diabetes. Rus Med J. 2012;(5):51-53. (In Russian).
  12. Balzan S, de Almeida Quadros C, de Cleva R, Zilberstein B, Cecconello I. Bacterial translocation: overview of mechanisms and clinical impact. J Gastroenterol Hepatol. 2007 Apr;22(4):464-71. Review. PubMed, CrossRef
  13. Rajagopalan S. Serious infections in elderly patients with diabetes mellitus. Clin Infect Dis. 2005 Apr 1;40(7):990-6. Review. PubMed, CrossRef
  14. Gordienko AI. Correlation between basal concentration of C-reactive protein in the blood, levels of serum antiendotoxin antibodies and endotoxin-binding capacity of monocytes and granulocytes in healthy people. Ukr Biokhim Zhurn. 2013 Jul-Aug;85(4):61-6. (In Russian). PubMed, CrossRef
  15. Dedov II, Balabolkin MI, Klebanova EM, Kreminskaya VM, Chazova TE. Diabetes: pathogenesis, classification, diagnosis and treatment: a Manual for physicians. M., 2003; 170 p. (In Russian).
  16. Gordienko AI. New approach to an increase of specificity in determination of antibodies to lipopolysaccharides of Gram–negative bacteria by solid–phase enzyme–linked immunosorbent assay. Ukr Biokhim Zhurn. 2004 Nov-Dec;76(6):130-5. (In Russian). PubMed
  17. Gordienko An. I., Beloglazov V. A., Gordienko Al. I. Microturbidimetry method for the determination of human IgG, IgM, IgA. Immunol. Allergol. 2000;(1):12-15. (In Russian).
  18. Zhizhin KC. Medical statistics. Rostov n. D: Phoenix, 2007; 160 p. (In Russian).
  19. Rebrova OYu. Statistical analysis of medical data. Application of package STATISTICA. M.: MediaSphera, 2002;. 312 p. (In Russian).
  20. Neves AL, Coelho J, Couto L, Leite-Moreira A, Roncon-Albuquerque R Jr. Metabolic endotoxemia: a molecular link between obesity and cardiovascular risk. J Mol Endocrinol. 2013 Sep 11;51(2):R51-64. Print 2013 Oct. Review. PubMed, CrossRef
  21. Wolter J, Liehr H, Grün M. Hepatic clearance of endotoxins: differences in arterial and portal venous infusion. J Reticuloendothel Soc. 1978 Feb;23(2):145-52. PubMed
  22. Everard A, Cani PD. Diabetes, obesity and gut microbiota. Best Pract Res Clin Gastroenterol. 2013 Feb;27(1):73-83. Review. PubMed, CrossRef
  23. Okorokov PL, Anikhovskaia IA, Volkov IE, Iakovlev MIu. Intestinal endotoxin in induction of type 1 diabetes. Fiziol Cheloveka. 2011 Mar-Apr;37(2):138-41. Russian. PubMed
  24. Al-Attas OS, Al-Daghri NM, Al-Rubeaan K, da Silva NF, Sabico SL, Kumar S, McTernan PG, Harte AL.  Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies. Cardiovasc Diabetol. 2009 Apr 15;8(1):20. PubMedPubMedCentral, CrossRef
  25. Black S, Kushner I, Samols D. C-reactive Protein. J Biol Chem. 2004 Nov 19;279(47):48487-90. Review. PubMed, CrossRef
  26. Noveck R, Stroes ES, Flaim JD, Baker BF, Hughes S, Graham MJ, Crooke RM, Ridker PM. Effects of an antisense oligo­nucleotide inhibitor of C-reactive protein synthesis on the endotoxin challenge response in healthy human male volunteers. J Am Heart Assoc. 2014 Jun;3(4):e001084. PubMed, PubMedCentral, CrossRef

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.